The contribution made to the field of study emerges from the need to find and establish novel compounds with therapeutic action in RA to address the current limitations, with the present study addressing the possible interactions with JAK1, JAK2, and JAK3 through a distinct design. The gene discussed is JAK3; the disease is rheumatoid arthritis.